Trials show No Advantage for ABMT In Breast Cancer; Should Insurers Pay?
In Brief; “Sense of Urgency” In Research Is Theme of New AACR President Daniel Von Hoff
Clinical Trials: ECOG Says Results In Metastatic disease equivalent, Unlikely To change Over Time
CALGB Says Results In Adjuvant Setting Too Preliminary; Follow Up Planned In Three Years
Komen, ACS Support Payment Off-Protocol; Dilemma for Advocates
NCI Programs: Pediatric Brain Tumor Grants Awarded
Trending Stories
- ACOG says it will no longer accept federal funding
- Gardiner Harris, acclaimed health care and pharma journalist, on his New York Times bestselling book
- Knight Cancer Institute receives record-setting $2B gift from the Knights—and self-governance within OHSU
Brian Druker returns to executive role as president of the new Knight Cancer Group - Robert A. Winn on his new vision to train cancer center leaders: “I had a big bold idea and an ‘Aha!’ moment.”
- Pediatric cancer research cut from spending legislation at last minute
Republicans quietly removed hard-won pediatric cancer bills - “If I’m not dying, I better go live.” Christy Erickson’s cancer diagnosis led to life as a motorcyclist and strongman competitor